3651 results for «315»
3651 results
Welcome introduction
15 May 2017 – From PCR Innovators Day 2017
Discover the latest innovative and disruptive technologies and key opinion leaders in interventional cardiology during the opening ceremony by W Wijns during PCR Innovators Day Paris 2017.
EAPCI Fellows Course - Opening
15 May 2017 – From EuroPCR 2017
Welcome to the European Interventional Cardiology Fellows Course - Opening, consult this session if you want to find out more about the course hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on Monday 15 and Tuesday morning 16 May.
These presentations were part of the EAPCI...
EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony
19 May 2017 – From EuroPCR 2017
Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.
EuroPCR 2017 Closing Ceremony
19 May 2017 – From EuroPCR 2017
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
GulfPCR-GIM 2017 Opening Ceremony
13 Dec 2017 – From GulfPCR-GIM 2017
Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...
GulfPCR-GIM 2017 Award and Closing Ceremony
14 Dec 2017 – From GulfPCR-GIM 2017
Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
